Xtl Biopharmaceuticals (XTLB) Payables (2009 - 2025)
Xtl Biopharmaceuticals (XTLB) posted quarterly Payables of $289000.0 for Q4 2025, down 68.86% year-on-year from $928000.0 in Q4 2024, and down 60.08% on a QoQ basis from $724000.0 in Q2 2025.
Xtl Biopharmaceuticals (XTLB) Payables (2009 - 2025) Analysis & Trends
Xtl Biopharmaceuticals (XTLB) has reported Payables for 17 consecutive years, with $289000.0 the latest figure, recorded in Q4 2025.
- Quarterly Payables fell 68.86% year-over-year to $289000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $289000.0 (down 68.86% YoY) and the FY2025 annual result came in at $289000.0, down 68.86% from the prior year.
- Payables eased to $289000.0 in Q4 2025 per XTLB's latest filing, from $724000.0 in the prior quarter.
- Over the last five years, Payables for XTLB reached as high as $928000.0 in Q4 2024 and fell as low as $153000.0 in Q3 2022.
- A 5-year average of $321600.0 and a median of $223000.0 in 2024 frame the typical range for Payables.
- Annual changes were most pronounced in 2024 — Payables surged 350.49% — and 2025, when it sank 68.86%.
- Year by year, Payables stood at $231000.0 in 2021, then fell by 19.05% to $187000.0 in 2022, then increased by 10.16% to $206000.0 in 2023, then jumped by 350.49% to $928000.0 in 2024, then plunged by 68.86% to $289000.0 in 2025.
- According to Business Quant data, Payables over the past three periods registered $289000.0, $724000.0, and $928000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - | 289,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 289,000.00 |
| Jun 30, 2025 | 724,000.00 |
| Dec 31, 2024 | 928,000.00 |
| Sep 30, 2024 | 722,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Mar 31, 2024 | 223,000.00 |
| Dec 31, 2023 | 206,000.00 |
| Sep 30, 2023 | 162,000.00 |
| Jun 30, 2023 | 163,000.00 |
| Mar 31, 2023 | 241,000.00 |
| Dec 31, 2022 | 187,000.00 |
| Sep 30, 2022 | 153,000.00 |
| Jun 30, 2022 | 172,000.00 |
| Dec 31, 2021 | 231,000.00 |
| Jun 30, 2021 | 258,000.00 |
| Dec 31, 2020 | 254,000.00 |
| Dec 31, 2019 | 232,000.00 |
| Dec 31, 2018 | 253,000.00 |
| Dec 31, 2017 | 300,000.00 |
| Dec 31, 2016 | 17,000.00 |